ATE330620T1 - Verwendung von midkin oder von anti-midkin antikörper - Google Patents
Verwendung von midkin oder von anti-midkin antikörperInfo
- Publication number
- ATE330620T1 ATE330620T1 AT98931102T AT98931102T ATE330620T1 AT E330620 T1 ATE330620 T1 AT E330620T1 AT 98931102 T AT98931102 T AT 98931102T AT 98931102 T AT98931102 T AT 98931102T AT E330620 T1 ATE330620 T1 AT E330620T1
- Authority
- AT
- Austria
- Prior art keywords
- midkin
- antibodies
- midkine
- inducible
- heparin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20532097 | 1997-07-14 | ||
JP20533297 | 1997-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE330620T1 true ATE330620T1 (de) | 2006-07-15 |
Family
ID=26515003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98931102T ATE330620T1 (de) | 1997-07-14 | 1998-07-14 | Verwendung von midkin oder von anti-midkin antikörper |
Country Status (10)
Country | Link |
---|---|
US (1) | US7390491B2 (de) |
EP (1) | EP0998941B9 (de) |
JP (1) | JP2010215673A (de) |
KR (1) | KR100571010B1 (de) |
CN (1) | CN1287852C (de) |
AT (1) | ATE330620T1 (de) |
AU (1) | AU756279B2 (de) |
CA (1) | CA2296409C (de) |
DE (1) | DE69835016T2 (de) |
WO (1) | WO1999003493A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL139030A0 (en) * | 1998-04-17 | 2001-11-25 | Angiogenix Inc | Therapeutic angiogenic factors and methods for their use |
KR100608276B1 (ko) * | 1998-08-24 | 2006-08-02 | 무라마쯔 다카시 | 동맥경화 및 ptca술후의 혈관 재협착에 대한예방·치료제 |
US20060259026A1 (en) * | 2005-05-05 | 2006-11-16 | Baylis Medical Company Inc. | Electrosurgical treatment method and device |
JP4768440B2 (ja) * | 2003-03-06 | 2011-09-07 | セルミド リミテッド | 開腹手術後の癒着の予防剤 |
WO2004085642A1 (ja) * | 2003-03-27 | 2004-10-07 | Takashi Muramatsu | 関節炎関連遺伝子及びこれの関節炎検査等への利用 |
JP5398987B2 (ja) * | 2005-11-14 | 2014-01-29 | セルミド リミテッド | 調節性t細胞の機能異常に基づく疾患の治療方法及び予防方法 |
CA2669523C (en) * | 2006-11-14 | 2016-06-21 | Ribomic Inc. | Aptamer against midkine and use thereof |
EP2088159B1 (de) | 2006-11-14 | 2014-03-05 | Medical Therapies Limited | Die c-domäne von midkin erkennenden antikörpern |
WO2010074218A1 (ja) * | 2008-12-25 | 2010-07-01 | 株式会社イーベック | 抗ヒトミッドカイン抗体 |
US20110212181A1 (en) * | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
US9624294B2 (en) | 2011-03-14 | 2017-04-18 | Cellmid Limited | Antibody recognizing N-domain of midkine |
AU2013297478B2 (en) | 2012-07-30 | 2018-12-20 | Medical & Biological Laboratories Co., Ltd. | Monoclonal antibody against human midkine |
KR101985300B1 (ko) * | 2016-07-19 | 2019-06-03 | 삼성전자주식회사 | 미드카인 저해제를 포함하는 뇌종양 치료 또는 예방용 약학 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206223A (en) | 1986-06-26 | 1993-04-27 | Yeda Research And Development Co. Ltd. | Method for inhibiting heparanase activity |
IL79254A0 (en) * | 1986-06-26 | 1986-09-30 | Hadassah Med Org | Compositions for preventing graft rejection |
US5210026A (en) | 1990-08-20 | 1993-05-11 | American Cyanamid Company | Human mk gene and method of expression |
DE69232615T2 (de) | 1991-05-02 | 2003-01-30 | Cohen, Irun R. | Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen |
EP0535336A3 (en) * | 1991-09-30 | 1993-05-19 | American Cyanamid Company | Mk protein as cell growth inhibitor |
US5461029A (en) * | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
EP0754460B1 (de) | 1995-02-07 | 2002-06-05 | Shiseido Company Limited | Anti-inflamatorische agenzien |
JPH08277224A (ja) * | 1995-02-07 | 1996-10-22 | Shiseido Co Ltd | 抗炎症剤 |
US5629284A (en) * | 1995-07-24 | 1997-05-13 | Meiji Milk Products Co., Ltd. | Method for treating retinal diseases |
JPH0995454A (ja) | 1995-10-02 | 1997-04-08 | Meiji Milk Prod Co Ltd | 抗潰瘍組成物 |
CA2260014A1 (en) | 1996-07-10 | 1998-01-15 | Meiji Milk Products Co., Ltd. | Novel use of mk family as hematopoietic factor |
-
1998
- 1998-07-14 AT AT98931102T patent/ATE330620T1/de not_active IP Right Cessation
- 1998-07-14 DE DE69835016T patent/DE69835016T2/de not_active Expired - Lifetime
- 1998-07-14 AU AU81310/98A patent/AU756279B2/en not_active Ceased
- 1998-07-14 CN CNB988089343A patent/CN1287852C/zh not_active Expired - Fee Related
- 1998-07-14 EP EP98931102A patent/EP0998941B9/de not_active Expired - Lifetime
- 1998-07-14 WO PCT/JP1998/003161 patent/WO1999003493A1/ja active IP Right Grant
- 1998-07-14 CA CA2296409A patent/CA2296409C/en not_active Expired - Fee Related
- 1998-07-14 KR KR1020007000378A patent/KR100571010B1/ko not_active IP Right Cessation
-
2002
- 2002-11-18 US US10/298,889 patent/US7390491B2/en not_active Expired - Fee Related
-
2010
- 2010-07-09 JP JP2010156986A patent/JP2010215673A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999003493A1 (fr) | 1999-01-28 |
CA2296409A1 (en) | 1999-01-28 |
EP0998941B1 (de) | 2006-06-21 |
AU756279B2 (en) | 2003-01-09 |
DE69835016T2 (de) | 2007-06-28 |
AU8131098A (en) | 1999-02-10 |
EP0998941A4 (de) | 2004-05-12 |
US20030072739A1 (en) | 2003-04-17 |
KR100571010B1 (ko) | 2006-04-13 |
JP2010215673A (ja) | 2010-09-30 |
CN1306435A (zh) | 2001-08-01 |
CN1287852C (zh) | 2006-12-06 |
EP0998941A1 (de) | 2000-05-10 |
EP0998941B9 (de) | 2007-03-14 |
DE69835016D1 (de) | 2006-08-03 |
US7390491B2 (en) | 2008-06-24 |
KR20010021814A (ko) | 2001-03-15 |
CA2296409C (en) | 2010-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69835016D1 (de) | Verwendung von midkin oder von anti-midkin antikörper | |
DE3667378D1 (de) | Verwendung von n-(4-phenoxy-2,6-diisopropylphenyl)-n'-tert.butylthioharnstoff zur bekaempfung von weissen fliegen. | |
ATE454141T1 (de) | Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten | |
FI946004A0 (fi) | Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio | |
FI920992A (fi) | Foerfarande foer framstaellning av i industriell skala av ett standardiserat koncentrat av human von willebrand-faktor, vilket har synnerligen hoeg renhet och aer laempligt foer terapeutisk anvaendning | |
DE69822665D1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
ATE413885T1 (de) | Getrocknete blutfaktorzusammensetzung mit trehalose | |
ATE339505T1 (de) | Antagoniste von interleukin-15 | |
CO4830493A1 (es) | Anticuerpos contra cd40 humano | |
ATA76995A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen | |
ATE198895T1 (de) | Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten | |
DE69001839D1 (de) | 1-hydroxyvitamin d2-epimer und dessen derivate. | |
EA199900279A1 (ru) | Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью | |
DE3774858D1 (de) | Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren. | |
DE3680000D1 (de) | Stabilisierte aktive formen von vitamin-d3. | |
DE69624707D1 (de) | Therapeutische verwendung von 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonsäure und ihre salze | |
ATE208042T1 (de) | Hapten-analoge zur verwendung in immunoassays | |
DE59806627D1 (de) | Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen | |
BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
BR9612196A (pt) | Tiazolinas substituidas | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
ATE341293T1 (de) | Kortikalknochenimplantat für wirbelfusion nach smith-robinson | |
DE69227805D1 (de) | Verwendung von Tri-n-Butylphosphat bei niedrigem pH in Lösungen von biologisch aktiven Proteinen für eine verbesserte viruzide Wirkung | |
DE3871712D1 (de) | Suspensionen und verwendung dieser suspensionen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |